Form 4: Inspire Medical Systems Officer Sells Shares
SEC Form 4 Filing
John Rondoni, Chief Product and Innovation Officer at Inspire Medical Systems, sold 1,734 shares of common stock at a price of $149.38 on May 19, 2025.
Summary
- On May 19, 2025, John Rondoni, Chief Product and Innovation Officer of Inspire Medical Systems, sold 1,734 shares of the company's common stock.
- The sale price was $149.38 per share.
- Following the transaction, Rondoni directly owns 13,766 shares of Inspire Medical Systems.
Sentiment
Score: 5
Explanation: The document is a standard regulatory filing regarding an insider transaction, which is neutral in sentiment.
Industry Context
This is a routine disclosure of an insider transaction. It's common for officers to periodically sell shares for personal financial management.
Stakeholder Impact
- The sale of shares by an officer could be perceived negatively by some shareholders, although it is a common practice.
Key Dates
| Date | Description |
|---|---|
| 05/19/2025 | Date of transaction: John Rondoni sold 1,734 shares of Inspire Medical Systems common stock. |
| 05/21/2025 | Date of signature on the Form 4 filing. |
Keywords
Form 4, Insider Trading, Share Sale, Inspire Medical Systems, INSP, John Rondoni
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.